Genova Biotherapeutics, Inc., formerly Kinder Travel Inc., is a development-stage company. The Company is a biotechnological drug development company. It focuses on identifying, evaluating and acquiring new drugs for treatment and prevention of oncological and infectious diseases in human beings. As of December 31, 2009, the Company held the rights to pending patent applications for three medicines. Patent applications for each of the three drugs are pending in Denmark and the United Kingdom, including prostate cancer treatment and breast cancer treatment. Its operations consist of acting as a holding company for the rights to the patent applications. Effective July 1, 2009, the Company disposed of its travel business operations.